Lumea is putting on the first conference of its kind: The Digital Diagnostic Summit. It focuses on the practical deployment of digital diagnostic technologies, not only in the pathology office, but also in the clinic and laboratory. The Summit is September 21-23, 2022, at the elite St. Regis Hotel in Park City, Utah. It will feature industry experts and peers discussing how to materially improve the quality of your practice, reduce costs, and grow your business with the latest technology solutions available.
Why should I attend the DDX Summit?
Going beyond the theoretical and aspirational, we will be dissecting strategies for the practical and successful use of digital pathology for primary diagnosis on a daily basis. Expert speakers will also share knowledge that can be applied to the clinic, lab, and pathology suite today. You will learn about:
- The regulatory landscape for digital pathology and AI.
- How technologies introduced at the clinic can work seamlessly with the lab and pathologist to bring value to all stakeholders, including the patient.
- The benefits of partnering with your pathologist to solve the complexities of genetic test ordering.
- How new technologies can standardize and streamline the ordering of molecular testing for all relevant patients.
Additionally, you get to spend time in beautiful Park City networking with peers and enjoying premier outdoor excursions.
Mike Leavitt is the founder of Leavitt Partners and the current chairman of Intermountain Healthcare. He served as the governor of Utah for three terms, Administrator of the Environmental Protection Agency. Later, he occupied the role of United States Secretary of Health and Human Services in the Cabinet of President George W. Bush.
Mike is a seasoned diplomat, leading U.S. delegations to more than 50 countries. He has conducted negotiations on matters related to health, the environment, and trade. At the conclusion of his service, the Chinese government awarded him the China Public Health Award – the first time this award has ever been given to a foreign government official.
Expert Guest Speakers
Our lineup of expert guest speakers and panelists at the Digital Diagnostic Summit includes a variety of practicing pathologist and professionals at the frontline of digital pathology. They are:
Dr. Martin Stumpe, Tempus Chief of AI, will be presenting about leveraging AI to identify patients who will benefit from precision medicine.
Verily Life Sciences representatives will talk about the advances and opportunities of artificial intelligence in digital pathology.
Dr. Thomas Slavin, Myriad Genetics Chief Medical Officer, will talk about genetic and genomic opportunities for pathology.
CEO and Founder of PathNet Labs, Dr. Matthew O Leavitt is an experienced pathologist with a passion for digital pathology. He will share his personal experience with digital pathology and insights into artificial intelligence.
Dr. Adam Cole is founder and CSO of TruCore Pathology. He reads more than 60,000 prostate samples every year for urology groups in nine states.
StarPath Founder and Co-Owner, Dr. Hillel Kahane, has more than 28 years of experience in the commercial USA laboratory industry. He has personally signed out over 1,000,000 prostate needle biopsies.
Dr. Ralph Hall will go in depth about the FDA and AI in digital pathology.
Representing the Open Pathology Network, Dr. Ngoc Tran will talk about the future of digital pathology. This network is a collaborative project aiming to improve human health by lowering the barriers to quality pathology education and training globally.
Expert Guest Moderators
Dr. Joseph Anderson, Host of Digital Pathology Today. He oversaw the clinical pathology group at Genomic Health as the Oncotype Dx breast cancer assay grew to a volume of over half a million tests. He will moderate a fireside chat panel at the Digital Diagnostics Summit.
Expert Guest Panelists
The Digital Diagnostic Summit will include two panels with a variety of expert guests to weigh in on the topics of AI in digital pathology and digital pathology in the real world, the puts and takes. Some of these panelists include:
Dan Thompson has 30 years of commercial leadership experience in cancer biomarkers and clinical education. He is currently with AstraZeneca Oncology as the Precision Medicine Field Director. He is an expert in cancer biomarkers, advanced testing protocols, oncology data partnerships, and clinical decision tools.
Dr. Kirk Wojno, MDPath Founder and Co-Owner, has over 30 years of experience in positions ranging from laboratory director, medical director, director of clinical research, and chief medical officer. He is also an active member of the College of American Pathologists.
Dr. Nike Beaubier, Tempus Senior Vice President, Life Science Pathology, is an experienced anatomic pathologist and medical director. She will provide key insight into one of her specialties; molecular genetic pathology.
Dr. Nicole Massoll, xMD Diagnostics, Inc.’s Medical Director, was one of the first cytopathologists to learn Ultrasound guided Fine Needle Aspiration procedures. She has performed thousands of thyroid US guided FNAs.